MIDDLE EAST AND ASIA PACIFIC CELL AND GENE THERAPY MARKET ANALYSIS

Middle East and Asia Pacific Cell and Gene Therapy Market, by Therapy Type (Cell Therapy (Stem Cells, T Cells, Dendritic Cells, and NK Cells) and Gene Therapy (Germline Gene Therapy and Somatic Gene Therapy)), by Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others), by Technology (Lentiviral Vector, Plasmid DNA, and AAV), and by Region (Middle East and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Mar 2022
Code : CMI4981
Pages :425
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Middle East: Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, and Rest of Middle East

Asia Pacific: South East Asia (Philippines, Malaysia, Singapore, Thailand, Vietnam and Rest of South East Asia), Taiwan, Hong Kong, Macau, Japan, South Korea, India, Australia, China, and Rest of Asia Pacific